mr antagonist
Two mineralocorticoid receptor antagonists, spironolactone and eplerenone, are currently approved by the FDA. Several non-steroid based ligands are in ... ,Mineralocorticoid receptor (MR) antagonist spironolactone (SPL) is an effective agent for prevention of cardiovascular injury. However, whether and how SPL ...
| 相關軟體 FeedDemon 資訊 | |
|---|---|
 mr antagonist 相關參考資料
Antimineralocorticoid - Wikipedia
An antimineralocorticoid, also known as a mineralocorticoid receptor antagonist (MCRA) or aldosterone antagonist, is a diuretic drug which antagonizes the ... https://en.wikipedia.org Mineralocorticoid Antagonist - an overview | ScienceDirect ...
Two mineralocorticoid receptor antagonists, spironolactone and eplerenone, are currently approved by the FDA. Several non-steroid based ligands are in ... https://www.sciencedirect.com Mineralocorticoid receptor antagonist spironolactone prevents ...
Mineralocorticoid receptor (MR) antagonist spironolactone (SPL) is an effective agent for prevention of cardiovascular injury. However, whether and how SPL ... https://pubmed.ncbi.nlm.nih.go Mineralocorticoid Receptor Antagonists for Treatment of ...
Spironolactone and eplerenone are both mineralocorticoid-receptor antagonists. These compounds block both the epithelial and nonepithelial actions of ... https://www.ncbi.nlm.nih.gov Mineralocorticoid Receptor Antagonists in ESKD | American ...
2020年7月1日 — The two commonly used mineralocorticoid receptor antagonists are spironolactone and eplerenone, although these agents are currently not ... https://cjasn.asnjournals.org Mineralocorticoid Receptor Antagonists | DrugBank Online
Canrenoic acid (as the salt potassium canrenoate) is an aldosterone antagonist. Like spironolactone, it is a prodrug, which is metabolized to canrenone in the ... https://go.drugbank.com Mineralocorticoid receptor antagonists: their use and ... - Nature
2012年11月22日 — Mineralocorticoid receptor (MR) antagonists are considered to be potassium-sparing diuretics that exert their effect by blocking MR in the kidney. https://www.nature.com Third Generation Mineralocorticoid Receptor Antagonists ...
Abstract. The first mineralocorticoid receptor (MR) antagonist, spironolactone, was developed almost 60 years ago to treat primary aldosteronism and pathological ... https://www.ncbi.nlm.nih.gov 抗鹽皮質激素- 維基百科，自由的百科全書 - Wikipedia
... 醛固酮拮抗劑"(aldosterone antagonist)、醛固酮受體拮抗劑、醛甾酮拮抗劑)是指一種利尿劑能拮抗在鹽皮質激素受體(Mineralocorticoid receptor)的醛固酮作用。 https://zh.wikipedia.org 臺中榮總藥訊 - 台中榮總
(mineralocorticoid receptor antagonist,. MRA)，由於不具選擇性，除了抑制. 醛固酮之外，同時也抑制了男性激素. (androgen)、黃體激素(progesterone)、. http://www.vghtc.gov.tw |